Catalyst Wire Dossier Catalyst Wire Dossier

TMC435350

· Tibotec Pharmaceuticals, Ireland
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for TMC435350, covering 2010-04-28 to 2014-07-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Anti-viral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 in Participants Infected With Hepatitis C-Virus (HCV) [Phase 2]

See pricing